Literature DB >> 6859878

The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase.

N Chacos, J Capdevila, J R Falck, S Manna, C Martin-Wixtrom, S S Gill, B D Hammock, R W Estabrook.   

Abstract

Epoxyeicosatrienoic acids, formed during the cytochrome P-450-catalyzed oxidation of arachidonic acid, react with a liver cytosolic epoxide hydrolase to form vicinal diols of eicosatrienoic acid. The role of this cytosolic enzyme, rather than a microsomal bound type, explains previous results illustrating the ability to accumulate epoxides during the in vitro aerobic steady state of oxidative metabolism of arachidonic acid by liver microsomes. The inability of the 5,6-epoxyeicosatrienoic acid to serve as a suitable substrate for this enzyme is discussed in light of recent studies concerning possible unique physiological functions for this metabolite.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859878     DOI: 10.1016/0003-9861(83)90628-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  56 in total

Review 1.  EET signaling in cancer.

Authors:  Dipak Panigrahy; Emily R Greene; Ambra Pozzi; Dao Wen Wang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Analysis of epoxyeicosatrienoic acids by chiral liquid chromatography/electron capture atmospheric pressure chemical ionization mass spectrometry using [13C]-analog internal standards.

Authors:  Clementina Mesaros; Seon Hwa Lee; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2010-11-30       Impact factor: 2.419

3.  Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.

Authors:  Dong Sun; Azita J Cuevas; Katherine Gotlinger; Sung Hee Hwang; Bruce D Hammock; Michal L Schwartzman; An Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

4.  The arachidonic acid monooxygenase: from biochemical curiosity to physiological/pathophysiological significance.

Authors:  Jorge H Capdevila; John R Falck
Journal:  J Lipid Res       Date:  2018-08-28       Impact factor: 5.922

Review 5.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

Review 6.  The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

Authors:  Sean D Kodani; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2015-03-11       Impact factor: 3.922

7.  Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.

Authors:  Kimberly L Fife; Yingmei Liu; Kara R Schmelzer; Hsing-Ju Tsai; In-Hae Kim; Christophe Morisseau; Bruce D Hammock; Deanna L Kroetz
Journal:  J Pharmacol Exp Ther       Date:  2008-09-24       Impact factor: 4.030

8.  The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity.

Authors:  John W Newman; Christophe Morisseau; Todd R Harris; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

9.  Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain.

Authors:  Bora Inceoglu; Ahmed Bettaieb; Carlos A Trindade da Silva; Kin Sing Stephen Lee; Fawaz G Haj; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

Review 10.  Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Authors:  Dipak Panigrahy; Arja Kaipainen; Emily R Greene; Sui Huang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.